Works by Lheureux, Stéphanie

Results: 10
    1

    Towards a new standardized method for circulating miRNAs profiling in clinical studies: Interest of the exogenous normalization to improve miRNA signature accuracy.

    Published in:
    Molecular Oncology, 2016, v. 10, n. 7, p. 981, doi. 10.1016/j.molonc.2016.03.005
    By:
    • Vigneron, Nicolas;
    • Meryet-Figuière, Matthieu;
    • Guttin, Audrey;
    • Issartel, Jean-Paul;
    • Lambert, Bernard;
    • Briand, Mélanie;
    • Louis, Marie-Hélène;
    • Vernon, Mégane;
    • Lebailly, Pierre;
    • Lecluse, Yannick;
    • Joly, Florence;
    • Krieger, Sophie;
    • Lheureux, Stéphanie;
    • Clarisse, Bénédicte;
    • Leconte, Alexandra;
    • Gauduchon, Pascal;
    • Poulain, Laurent;
    • Denoyelle, Christophe
    Publication type:
    Article
    2

    FDG PET/CT for assessing tumour response to immunotherapy.

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2019, v. 46, n. 1, p. 238, doi. 10.1007/s00259-018-4171-4
    By:
    • Aide, Nicolas;
    • Fanti, Stefano;
    • Lopci, Egesta;
    • Hicks, Rodney J.;
    • Le Tourneau, Christophe;
    • Lheureux, Stéphanie
    Publication type:
    Article
    3
    4
    5

    Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study.

    Published in:
    BJU International, 2015, v. 115, n. 1, p. 65, doi. 10.1111/bju.12552
    By:
    • Joly, Florence;
    • Delva, Remy;
    • Mourey, Loïc;
    • Sevin, Emmanuel;
    • Bompas, Emmanuelle;
    • Vedrine, Lionel;
    • Ravaud, Alain;
    • Eymard, Jean‐Christophe;
    • Tubiana‐Mathieu, Nicole;
    • Linassier, Claude;
    • Houede, Nadine;
    • Guillot, Aline;
    • Ringensen, François;
    • Cojocarasu, Oana;
    • Valenza, Bruno;
    • Leconte, Alexandra;
    • Lheureux, Stéphanie;
    • Clarisse, Bénédicte;
    • Oudard, Stéphane
    Publication type:
    Article
    6
    7

    Identification of predictive factors of response to the BH3-mimetic molecule ABT-737: An ex vivo experiment in human serous ovarian carcinoma.

    Published in:
    International Journal of Cancer, 2015, v. 136, n. 5, p. E340, doi. 10.1002/ijc.29104
    By:
    • Lheureux, Stéphanie;
    • N'Diaye, Monique;
    • Blanc‐Fournier, Cécile;
    • Dugué, Audrey Emmanuelle;
    • Clarisse, Bénédicte;
    • Dutoit, Soizic;
    • Giffard, Florence;
    • Abeilard, Edwige;
    • Briand, Mélanie;
    • Labiche, Alexandre;
    • Grellard, Jean‐Michel;
    • Crouet, Hubert;
    • Martin, Sandrine;
    • Joly, Florence;
    • Poulain, Laurent
    Publication type:
    Article
    8
    9
    10

    DOMENICA study (GINECO-EN105b/ENGO-Ten13): randomized phase III trial in MMR deficient (MMRd) endometrial cancer (EC) patients comparing chemotherapy (CT) alone versus dostarlimab in first line advanced/metastatic setting (APGOT-EN1).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 19, doi. 10.3802/jgo.2024.35.S2.P1
    By:
    • Chel Hun Choi;
    • Ray-Coquard, Isabelle;
    • Rubio, Maria Jesus;
    • Paoletti, Xavier;
    • Hudson, Emma;
    • Lorusso, Domenica;
    • Hasler-Strub, Ursula;
    • Vardar, Mehmet Ali;
    • Lheureux, Stéphanie;
    • Van Gorp, Toon;
    • Shao Peng Tan, David;
    • Trillsch, Fabian;
    • Eberst, Lauriane;
    • Lescure, Céline;
    • Hardy-Bessard, Anne-Claire;
    • Chaix, Marie;
    • Byoung-Gie Kim;
    • JaeWeon Kim;
    • JeongYeol Park;
    • Jung-Yun Lee
    Publication type:
    Article